Literature DB >> 16735086

Enhanced transdermal-immunization with diptheria-toxoid using local hyperthermia.

Pramod Upadhyay1.   

Abstract

In this study we have investigated how mild local hyperthermia could be used for transdermal-immunization. Mild hyperthermia is found unique in many ways. It activates the immune system and it also results in higher mass transport of high molecular weight molecules and nanometer size quantum dots labeled antigens across the skin in experimental animals. Hyperthermia increases the expression of co-stimulatory molecules such as CD80 and CD86. Mice transdermally immunized with diphtheria toxoid, without any adjuvant or penetration enhancing reagent but under the conditions of local hyperthermia generate an antibody response. In the memory recall assay, the splenocytes of hyperthermia enhanced transdermal-immunized mice undergo proliferation, when exposed to diphtheria toxoid. Comparable response was generated when mice were immunized with diphtheria toxoid by hyperthermia enhanced transdermal route or by conventional inter-muscular injection. Hyperthermia enhanced transdermal-immunization procedure is likely to have higher compliance as it does not cause any pain or visible damage to the skin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735086     DOI: 10.1016/j.vaccine.2006.04.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules.

Authors:  Grace Tan; Peng Xu; Louise B Lawson; Jibao He; Lucia C Freytag; John D Clements; Vijay T John
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

2.  Adjuvant properties of thermal component of hyperthermia enhanced transdermal immunization: effect on dendritic cells.

Authors:  Neha Joshi; Vikas Duhan; Neelam Lingwal; Sangeeta Bhaskar; Pramod Upadhyay
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.